Change region or lenguage

Demonstrating the benefit of digital solutions in healthcare

Clinical evidence

Digital health solutions are rapidly growing and have the potential to revolutionize healthcare. A rising number of companies and increasing investment in digital health have marked the past decade.

A person interacting with a digital interface displaying an electronic medical record, vital signs and medical icons representing the nervous system, respiratory system and cardiovascular system.

navify® portfolio selected publications

navify® Clinical Hub for Tumor Boards

A digital tumor board solution impacts case discussion time and postponement of cases in tumor boards

Hammer, R. D., et al., 2021. Health and Technology, pp.1-9.

Digital tumor board solutions have significant impact on case preparation

Hammer, R. D., et al., 2020. JCO Clinical Cancer Informatics, 4, pp.757-768.

A clinician's perspective on co-developing and co-implementing a digital tumor board solution

Hammer, R. D. and Prime, M.S., 2020. Health Informatics Journal, 26(3), pp.2213-2221.

A new software platform to improve multidisciplinary tumor board workflows and user satisfaction: A pilot study

Krupinski, E. A., et al., 2018. Journal of pathology informatics, 9.

navify® Mutation Profiler

Assessment of a highly curated somatic oncology database

Stephanie J. Yaung, Ph.D. 2020. JMD Journal, Vol. 22, No. 11

Digital health perspectives

Challenges for the evaluation of digital health solutions - A call for innovative evidence generation approaches

Guo, C., et al., 2020. npj Digital Medicine, 3(1), pp.1-14.

Abstracts and posters from scientific meetings

navify® Clinical Hub for Tumor Boards

A mixed methods study for the evaluation of a digital health solution for cancer multidisciplinary team meetings using simulation-based research methods

Gardner C., et al. Presented at ASCO 2020.

Clinical decision support applications

A digital solution to enable improved implementation and usability of NCCN Guidelines®

Guo, C., et al. JNCCN 18(3.5), pp.BIO20-026. Presented at NCCN2020.

Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer

Perakis SO, Weber S, Zhou Q, et al. Presented at ESMO2020.

Real-world evidence

Clinical impact of adherence to NCCN biomarker testing guidelines on survival for patients with advanced non-squamous non-small-cell lung cancer

John A., et al. DOI: https://doi.org/10.6004/jnccn.2019.7441. Presented at 2020 NCCN Annual Meeting.

Disclaimer
  • Not every digital product is available in all markets. The use of any third-party app is subject to a separate license agreement with the respective third-party app developer. Roche gives no warranties (express or implied) with regard to any third-party app. Third-party apps might not be available in your country. This website and its content may be accessible worldwide, Roche assumes no liability with regard to the access to the information, which may not be compatible with legislations or regulations in force in your country.